Webinar series: Global Perspectives on Australia’s Cannabis Future

Webinar series Global Perspectives on Australia's Cannabis Future

Our popular webinar series, ‘Global Perspectives on Australia’s Cannabis Future’, is now available to watch on demand. Join us as we ask leading experts to share their cannabis policy insights from Australia and around the globe. Using real world examples and hard evidence, this webinar series tackles the big questions as we consider an Australian […]

Penington Institute urges Victorian Government to implement medicinal cannabis driving reform

Media release

Penington Institute endorses the recommendations of a report tabled in Victorian Parliament today that would allow judicial discretion to apply to motorists who use medicinal cannabis and are not impaired while driving. The report offers an interim proposal for a significant Victorian driving law reform, which would ensure that people who are prescribed medicinal cannabis […]

Nitazenes: Smarter monitoring, faster alerts

Webinar infographic with speaker's faces

https://www.youtube.com/watch?v=FfJYV5qFatU Join our panel of experts from across Australia and New Zealand for a crucial discussion on coordinating timely responses to synthetic opioids like nitazenes and other emerging drugs. Following the release of Australia’s Annual Overdose Report 2024 and our popular webinar, Nitazenes: An expert panel discussion, this webinar delves into how we can build […]

ABC News: Drug overdose deaths continue to climb as advocates slam ‘deplorable’ government inaction

Blonde middle aged woman looks directly into camera, ABC News logo overlay

In this ABC News story, Penington Institute CEO John Ryan discusses the sobering statistics revealed in Australia’s Annual Overdose Report 2024, while lived experience advocate Jen Furby shares her tragic story of losing her daughter to overdose. This story, Drug overdose deaths continue to climb as advocates slam ‘deplorable’ government inaction, by national health equity reporter […]

The Sydney Morning Herald: ‘Terrifying potency’: The overdose-inducing drug invading suburbia

2 bags of brightly coloured pills ona. table, with 'Sydney Morning Herald' overlay

As we launch Australia’s Annual Overdose Report 2024, Penington Institute CEO John Ryan discusses the increasing threat of nitazenes in Australia with the Sydney Morning Herald. In this article, ‘Terrifying potency’: The overdose-inducing drug invading suburbia, The Sydney Morning Hearld crime and justice reporter Amber Schultz highlights the rising number of opioid overdose deaths in Australia, […]

Jen’s story: Losing a loved one to overdose

Young woman holds a photo of another young man

Jen Furby is a Melbourne-based teacher whose only daughter, Nicole, died of a mixed-toxicity drug overdose in 2022. Nicole was 25. By sharing her tragic loss,  Jen hopes to start conversations and change community perceptions about drug overdose. This is her story. I didn’t know how to start this story, as I feel like there […]

Overdose in Australia: Findings from Australia’s Annual Overdose Report 2024

Webinar infographic - Findings from Australia's Annual Overdose Report 2024

Join our webinar for expert insights on the latest data on overdose in Australia, as we launch Australia’s Annual Overdose Report 2024. Penington Institute is pleased to invite you to our special webinar, offering an opportunity to engage with thought leaders and experts on overdose prevention in Australia. This year, we are honoured to be […]

Nitazenes: An expert panel discussion

Webinar infographic - Nitazenes: An expert Panel Discussion

Drawing on fresh lessons from overseas, Penington Institute presents this important webinar featuring an expert panel discussing strategies and responses to help prevent nitazene-related harms in Australia. There is global concern about the rising rates of harm due to nitazenes – a class of potent synthetic opioids that can be 50-500 times stronger than heroin […]

Your story can help drive change

Have drugs or current drug policies impacted you or someone you care about? We’d love to connect with you.